Key result
Radical nephrectomy and systemic chemotherapy fail to prevent fatal progression of primary renal synovial sarcoma.
Why the study?
Synovial sarcoma is a rare mesenchymal tumor and its occurrence as a primary renal tumor is exceedingly rare.
Case Report (n=1)
No
This case highlights the diagnostic challenges, limited treatment options, and poor prognosis associated with primary renal synovial sarcoma.
Answers are grounded in this paper and cite their sources.
Emphasizes fatal progression of renal synovial sarcoma despite nephrectomy and chemotherapy; leaves open need for effective therapies in this rare malignancy.
Synovial sarcoma is a rare mesenchymal tumor, and its occurrence as a primary renal tumor is exceedingly rare. We are presenting a case of renal synovial sarcoma with lung involvement in a 47-year-old female patient who initially presented with typical renal symptoms, including blood in urine and left flank pain. Imaging revealed a large renal mass with extension into the renal vein and metastatic nodules in the lungs. Histopathological examination and genetic analysis confirmed monophasic synovial sarcoma with SYT-SSX2 translocation. Treatment included radical nephrectomy followed by systemic chemotherapy with doxorubicin and ifosfamide. Despite the initial response, the disease progressed, leading to fatal complications. This case highlights the diagnostic challenges, limited treatment options, and poor prognosis associated with primary renal synovial sarcoma.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2024) conducted a case report in Primary Renal Synovial Sarcoma (n=1). Radical nephrectomy and systemic chemotherapy (doxorubicin and ifosfamide) was evaluated on Disease progression and survival. Despite radical nephrectomy and systemic chemotherapy, the patient's primary renal synovial sarcoma progressed, leading to fatal complications.
Synapse has enriched 10 related papers. Consider them for comparative context: